BridgeBio is a clinical-stage biotech company developing novel, genetically targeted therapies to improve the lives of patients. The BridgeBio approach combines a traditional focus on drug development with a unique corporate model, allowing rapid translation of early stage science into medicines that treat disease at its source.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Eidos Therapeutics Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Eidos Therapeutics Inc market cap is $4.75B.
What is the 52-week high for Eidos Therapeutics Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Eidos Therapeutics Inc 52 week high is $132.54 as of June 07, 2024.
What is the 52-week low for Eidos Therapeutics Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Eidos Therapeutics Inc 52 week low is $28.39 as of June 07, 2024.
What is Eidos Therapeutics Inc stock price today?
Eidos Therapeutics Inc stock price today is $122.21.
What was Eidos Therapeutics Inc stock price yesterday?
Eidos Therapeutics Inc stock price yesterday was $128.44.
What is the PE ratio of Eidos Therapeutics Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Eidos Therapeutics Inc’s P/E ratio is -46.10.
What is the Price-to-Book ratio of Eidos Therapeutics Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Eidos Therapeutics Inc P/B ratio is 38.3893.
What is the 50-day moving average of Eidos Therapeutics Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Eidos Therapeutics Inc 50-day moving average is $109.35.